METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT.
Introduction: Metoclopramide is a dopamine receptor agonist and well known antiemetic and gastrokynetic agent. Its usage has been restricted by European Medicines Agency (EMA), because of acute and chronic neurological adverse events. Extrapyramidal syndromes, including parkinsonism, tardive dyskine...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Peytchinski Publishing
2014-11-01
|
| Series: | Journal of IMAB |
| Subjects: | |
| Online Access: | http://www.journal-imab-bg.org/issue-2014/issue6/JofIMAB_2014-20-6p539-541.pdf |
| _version_ | 1811207806346330112 |
|---|---|
| author | Mirena Valkova Boyko Stamenov Dora Peychinska Ivanka Veleva Pepa Dimitrova Pavlina Radeva |
| author_facet | Mirena Valkova Boyko Stamenov Dora Peychinska Ivanka Veleva Pepa Dimitrova Pavlina Radeva |
| author_sort | Mirena Valkova |
| collection | DOAJ |
| description | Introduction: Metoclopramide is a dopamine receptor agonist and well known antiemetic and gastrokynetic agent. Its usage has been restricted by European Medicines Agency (EMA), because of acute and chronic neurological adverse events. Extrapyramidal syndromes, including parkinsonism, tardive dyskinesia, akathisia and acute dystonias, are the most reported and most often drug side effects.
Contingent and methods: We present a case of 23 years old woman with a 3-year history of Metoclopramide-induced recurrent oculogyric crises.
Results: The patient suffered from examinophobia, with minimal benzodiazepine symptoms relief. She willfully took small dosages of oral Metoclopramide for nausea relief before her examinations, which lead to recurrent oculogyric crises, short after the drug intake. After a detailed explanation of drug side effects and medicine discontinuation, they disappeared. She had no significant medical and family history of neurological and psychiatric conditions. Laboratory data were normal.
Conclusions: Metoclopramide could induce acute or chronic neurological conditions and its usage should be restricted in general population to some specific conditions. Some of its adverse reactions are often misdiagnosed and improperly treated. Critical drug anamnesis with a focus on Metoclopramide usage in some cases could enhance diagnosis. |
| first_indexed | 2024-04-12T04:11:09Z |
| format | Article |
| id | doaj.art-881c50fcc6294d15aac759e293400363 |
| institution | Directory Open Access Journal |
| issn | 1312-773X |
| language | English |
| last_indexed | 2024-04-12T04:11:09Z |
| publishDate | 2014-11-01 |
| publisher | Peytchinski Publishing |
| record_format | Article |
| series | Journal of IMAB |
| spelling | doaj.art-881c50fcc6294d15aac759e2934003632022-12-22T03:48:30ZengPeytchinski PublishingJournal of IMAB1312-773X2014-11-0120653954110.5272/jimab.2014206.539METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT.Mirena Valkova0Boyko Stamenov1Dora Peychinska2Ivanka Veleva3Pepa Dimitrova4Pavlina Radeva5Clinic of Neurology, UMHAT "Dr G. Stranski", Pleven, Bulgaria, Clinic of Neurology, UMHAT "Dr G. Stranski", Pleven, Bulgaria, Clinic of Neurology, UMHAT "Dr G. Stranski", Pleven, Bulgaria, Psychiatric Department, Medical University – Pleven, Bulgaria.Psychiatric Department, Medical University – Pleven, Bulgaria.Psychiatric Department, Medical University – Pleven, Bulgaria.Introduction: Metoclopramide is a dopamine receptor agonist and well known antiemetic and gastrokynetic agent. Its usage has been restricted by European Medicines Agency (EMA), because of acute and chronic neurological adverse events. Extrapyramidal syndromes, including parkinsonism, tardive dyskinesia, akathisia and acute dystonias, are the most reported and most often drug side effects. Contingent and methods: We present a case of 23 years old woman with a 3-year history of Metoclopramide-induced recurrent oculogyric crises. Results: The patient suffered from examinophobia, with minimal benzodiazepine symptoms relief. She willfully took small dosages of oral Metoclopramide for nausea relief before her examinations, which lead to recurrent oculogyric crises, short after the drug intake. After a detailed explanation of drug side effects and medicine discontinuation, they disappeared. She had no significant medical and family history of neurological and psychiatric conditions. Laboratory data were normal. Conclusions: Metoclopramide could induce acute or chronic neurological conditions and its usage should be restricted in general population to some specific conditions. Some of its adverse reactions are often misdiagnosed and improperly treated. Critical drug anamnesis with a focus on Metoclopramide usage in some cases could enhance diagnosis.http://www.journal-imab-bg.org/issue-2014/issue6/JofIMAB_2014-20-6p539-541.pdfMetoclopramide side effectsdopamine antagonistoculogyric crises |
| spellingShingle | Mirena Valkova Boyko Stamenov Dora Peychinska Ivanka Veleva Pepa Dimitrova Pavlina Radeva METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT. Journal of IMAB Metoclopramide side effects dopamine antagonist oculogyric crises |
| title | METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT. |
| title_full | METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT. |
| title_fullStr | METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT. |
| title_full_unstemmed | METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT. |
| title_short | METOCLOPRAMIDE – INDUCED EXTRAPYRAMIDAL SIGNS AND SYMPTOMS – BRIEF REVIEW OF LITERATURE AND CASE REPORT. |
| title_sort | metoclopramide induced extrapyramidal signs and symptoms brief review of literature and case report |
| topic | Metoclopramide side effects dopamine antagonist oculogyric crises |
| url | http://www.journal-imab-bg.org/issue-2014/issue6/JofIMAB_2014-20-6p539-541.pdf |
| work_keys_str_mv | AT mirenavalkova metoclopramideinducedextrapyramidalsignsandsymptomsbriefreviewofliteratureandcasereport AT boykostamenov metoclopramideinducedextrapyramidalsignsandsymptomsbriefreviewofliteratureandcasereport AT dorapeychinska metoclopramideinducedextrapyramidalsignsandsymptomsbriefreviewofliteratureandcasereport AT ivankaveleva metoclopramideinducedextrapyramidalsignsandsymptomsbriefreviewofliteratureandcasereport AT pepadimitrova metoclopramideinducedextrapyramidalsignsandsymptomsbriefreviewofliteratureandcasereport AT pavlinaradeva metoclopramideinducedextrapyramidalsignsandsymptomsbriefreviewofliteratureandcasereport |